July 30, 2012

Chobani has introduced two new versions of its popular Greek yogurt — 16-oz. blends and single-flavor six-packs.

July 30, 2012

Sales of over-the-counter medicines through alternate retail channels have grown by a compound annual growth rate of 9.4% from 2006 through 2011, far exceeding the 2.4% overall growth rate through all retail outlets, noted Kline in a report released Monday.

July 30, 2012

Lip Smacker is celebrating its 40th anniversary next year with an array of limited-edition flavors and promotions.

July 30, 2012

A provider of specialty pharmacy services to clients with chronic illnesses who need clotting factor, IVIg and other specialty pharmacy medications has been awarded specialty pharmacy accreditation from URAC.

July 30, 2012

In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.


July 30, 2012

Procter & Gamble’s Duracell brand, together with Powermat Technologies, have introduced Duracell Powermat, a 24-hour power system that works with iPhone 4 and 4S products.

July 30, 2012

Prestige Brands on Monday announced the home stretch for its consumer-created jingle-development contest for its Luden's cough drop brand.

July 30, 2012

La Roche-Posay has developed the new Redermic [C], an anti-wrinkle firming moisturizer that was inspired by the growing popularity of injectable filler technology.

July 30, 2012

The Food and Drug Administration has approved Watson Pharmaceuticals’ Next Choice One Dose (levonorgestrel) tablets in the 1.5-mg strength.

July 30, 2012

It’s a landmark switch decision that brings diagnosis of a stigmatized disease state into the self-care arena.

July 30, 2012

A number of smaller manufacturers of male contraceptives are launching into the market to challenge the big three: Church & Dwight (72.8% dollar share in the category), Ansell Healthcare (11.6% dollar share) and Reckitt Benckiser (11.5% dollar share).


July 30, 2012

Stiefel, a GlaxoSmithKline company, announced the availability of Sorilux foam by prescription.

July 30, 2012

Drug maker Takeda Pharmaceutical has resubmitted regulatory approval applications for two drugs designed to treat diabetes, the company said.

July 30, 2012

Unilever has put its North America frozen meals business on the sales block.

July 30, 2012

As reported by Drug Store News, toothpastes that aim to better deliver such 
value-added benefits as teeth whitening and relieving tooth sensitivity are resonating with consumers, so the lift in sales of such products comes as little surprise.


July 30, 2012

Generic drug maker Watson Pharmaceuticals is challenging the patent protection on a drug for acne and a drug for bronchospasm, the company said Monday.

July 30, 2012

Parents obviously want the best of the best for their little bundles of joy, and skin care products are no exception. That means often opting for those items that are free of such ingredients as artificial colors and parabens.


July 27, 2012

AmerisourceBergen on Thursday reported that in its fiscal-year third quarter ended June 30, diluted earnings per share were 71 cents, an 8% increase over the prior-year quarter.

July 27, 2012

Horizon Pharma announced it has received regulatory approval from the Food and Drug Administration for one of its drugs.

July 27, 2012

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

July 27, 2012

Gary J. Burns, 74, of Lake Forest, Ill., and Naples, Fla., passed away July 24. He was born Feb. 7, 1938, in Saginaw, Mich. Burns served in the U.S. Army and then embarked upon a long and successful career in the health and beauty aids industry.

July 27, 2012

McLane has entered into an agreement to acquire Meadowbrook Meat Co.

July 27, 2012

Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.

July 26, 2012

Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Wednesday introduced the Designer Anabolic Steroid Control Act, a bill that will protect consumers by providing the Drug Enforcement Administration with new enforcement tools to identify and quickly respond when new designer anabolic steroids are created and marketed as dietary supplements.